Back to top
more

Aurora Cannabis (ACB)

(Delayed Data from NSDQ)

$4.48 USD

4.48
1,765,197

+0.05 (1.13%)

Updated Aug 1, 2025 04:00 PM ET

After-Market: $4.48 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 30% (173 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Aurora Cannabis Inc. (ACB) Stock Moves -0.2%: What You Should Know

by Zacks Equity Research

Aurora Cannabis Inc. (ACB) closed the most recent trading day at $9.80, moving -0.2% from the previous trading session.

Zacks Equity Research

Aurora Cannabis Inc. (ACB) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Aurora Cannabis Inc. (ACB) closed at $9.51 in the latest trading session, marking a +1.06% move from the prior day.

Zacks Equity Research

Aurora Cannabis Inc. (ACB) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Aurora Cannabis Inc. (ACB) closed the most recent trading day at $10, moving -0.99% from the previous trading session.

Zacks Equity Research

Aurora Cannabis Inc. (ACB) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

Aurora Cannabis Inc. (ACB) closed the most recent trading day at $10.02, moving -1.96% from the previous trading session.

Zacks Equity Research

Aurora Cannabis Inc. (ACB) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Aurora Cannabis Inc. (ACB) closed at $10.71 in the latest trading session, marking a -0.19% move from the prior day.

Zacks Equity Research

Aurora Cannabis Inc. (ACB) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Aurora Cannabis Inc. (ACB) closed the most recent trading day at $11.88, moving -1.41% from the previous trading session.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Scotts Miracle-Gro, HEXO and Aurora Cannabis

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Scotts Miracle-Gro, HEXO and Aurora Cannabis

Tirthankar Chakraborty headshot

Get Ready for a Green Rush in the Second Half: 3 Must Buys

by Tirthankar Chakraborty

With more states in the US and Canada likely to legalize marijuana and calls for marijuana decriminalization growing louder, the cannabis industry is poised to bounce back in the second half.

Zacks Equity Research

Aurora Cannabis Inc. (ACB) Upgraded to Buy: Here's Why

by Zacks Equity Research

Aurora Cannabis Inc. (ACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Equity Research

Are Options Traders Betting on a Big Move in Aurora Cannabis (ACB) Stock?

by Zacks Equity Research

Investors need to pay close attention to Aurora Cannabis (ACB) stock based on the movements in the options market lately.

Zacks Equity Research

Zacks Market Edge Highlights: Canopy Growth, Aurora Cannabis, Hexo, GW Pharmaceuticals and Zynerba

by Zacks Equity Research

Zacks Market Edge Highlights: Canopy Growth, Aurora Cannabis, Hexo, GW Pharmaceuticals and Zynerba

Tracey Ryniec headshot

Is This a Buying Opportunity in the Marijuana Stocks?

by Tracey Ryniec

The marijuana stocks plunged during the coronavirus sell-off. Should investors be taking a second look?

Zacks Equity Research

How Aurora Cannabis (ACB) Stock Stands Out in a Strong Industry

by Zacks Equity Research

Aurora Cannabis (ACB) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Sweta Killa headshot

Cannabis ETF Tops in May: 5 Stocks That Led The Way

by Sweta Killa

Inside the best performing stocks in the top cannabis ETF of May.

Sanghamitra Saha headshot

How Cannabis ETFs Beat S&P 500 Past Month

by Sanghamitra Saha

Cannabis stocks and ETFs jumped last week. Here's why.

Zacks Equity Research

Aurora Cannabis Inc. (ACB) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Aurora Cannabis Inc. (ACB) delivered earnings and revenue surprises of -39.62% and 19.99%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Implied Volatility Surging for Aurora Cannabis (ACB) Stock Options

by Zacks Equity Research

Investors need to pay close attention to Aurora Cannabis (ACB) stock based on the movements in the options market lately.

Zacks Equity Research

Aurora Cannabis (ACB) to Report Q3 Earnings: What's in Store?

by Zacks Equity Research

Aurora Cannabis' (ACB) fiscal third-quarter results likely to reflect solid prospects in the Canadian market.

Zacks Equity Research

What's in Store for Ensign Group's (ENSG) Earnings in Q1?

by Zacks Equity Research

Ensign Group's (ENSG) Q1 results are likely to reflect a better revenue stream.

Sanghamitra Saha headshot

Are Marijuana Stocks, ETFs Poised for Upbeat Earnings?

by Sanghamitra Saha

"Essential Business" status tagged with marijuana selling amid lockdowns should have helped cannabis stocks and ETFs in the first quarter.

Zacks Equity Research

Aurora Cannabis Inc (ACB) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

Aurora Cannabis Inc (ACB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Cardinal Health (CAH) to Report Q3 Earnings: What's in Store?

by Zacks Equity Research

Cardinal Health's (CAH) fiscal third-quarter performance is likely to reflect solid performance in Pharmaceutical segment.

Trina Mukherjee headshot

3 Medical Product Stocks Set to Beat This Earnings Season

by Trina Mukherjee

Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on several factors.

Zacks Equity Research

Aurora Cannabis Inc. (ACB) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $0.70, marking a -1.55% move from the previous day.

Zacks Equity Research

How Hard Will Coronavirus Hit Zimmer Biomet (Zbh) Q1 Earnings?

by Zacks Equity Research

Zimmer Biomet (ZBH) may have registered improved performances within its Hips and Knees arms due to the nature of the businesses.